Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Amy A. Lo"'
Autor:
Alberto Valdeolivas, Bettina Amberg, Nicolas Giroud, Marion Richardson, Eric J. C. Gálvez, Solveig Badillo, Alice Julien-Laferrière, Demeter Túrós, Lena Voith von Voithenberg, Isabelle Wells, Benedek Pesti, Amy A. Lo, Emilio Yángüez, Meghna Das Thakur, Michael Bscheider, Marc Sultan, Nadine Kumpesa, Björn Jacobsen, Tobias Bergauer, Julio Saez-Rodriguez, Sven Rottenberg, Petra C. Schwalie, Kerstin Hahn
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-16 (2024)
Abstract The consensus molecular subtypes (CMS) of colorectal cancer (CRC) is the most widely-used gene expression-based classification and has contributed to a better understanding of disease heterogeneity and prognosis. Nevertheless, CMS intratumor
Externí odkaz:
https://doaj.org/article/d6bdaa8d602c4df587d26a3ae4c61323
Publikováno v:
Journal of Nutrition Education and Behavior. 55:343-353
Autor:
C. Andrew Boswell, Teemu T. Junttila, Saileta Prabhu, Mark S. Dennis, Sean B. Joseph, Kedan Lin, Klara Totpal, Robyn Clark, Maria Hristopoulos, Jason Ho, Dionysos Slaga, Jeffrey Eastham-Anderson, Ji Li, Amy A. Lo, Nene Takahashi, Danielle Mandikian
Anti-HER2/CD3, a T-cell–dependent bispecific antibody (TDB) construct, induces T-cell–mediated cell death in cancer cells expressing HER2 by cross-linking tumor HER2 with CD3 on cytotoxic T cells, thereby creating a functional cytolytic synapse.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e60ecae480ffb1c898949cde0e394c25
https://doi.org/10.1158/1535-7163.c.6539608.v1
https://doi.org/10.1158/1535-7163.c.6539608.v1
Autor:
Maxwell V. Meng, Oliver A. Zill, Ximo Pechuan-Jorge, Charles Havnar, Nicolas Lounsbury, Daniel Oreper, Amy A. Lo, Sima P. Porten, Andrew Wallace
Supplementary Data from Origins and Timing of Emerging Lesions in Advanced Renal Cell Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1108b84772ac5befd52a7f2259c87443
https://doi.org/10.1158/1541-7786.22528070
https://doi.org/10.1158/1541-7786.22528070
Autor:
Teemu T. Junttila, Yan Wu, Jian Payandeh, C. Andrew Boswell, Genee Lee, Klara Totpal, James Ziai, Diego Ellerman, Dionysos Slaga, Elaine Mai, Daniel Bravo-Perez, Meric Ovacik, Hao Cai, Thinh Pham, Debra Dunlap, Kathy Hötzel, Wei-Ching Liang, Dorothee Nickles, Robyn Clark, Maria Hristopoulos, Danielle Mandikian, Ji Li, Jennifer Johnston, Amy A. Lo
Supplementary Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04daf2ea0517ac17fcc1c07f5890422c
https://doi.org/10.1158/1535-7163.22522546
https://doi.org/10.1158/1535-7163.22522546
Autor:
C. Andrew Boswell, Teemu T. Junttila, Saileta Prabhu, Mark S. Dennis, Sean B. Joseph, Kedan Lin, Klara Totpal, Robyn Clark, Maria Hristopoulos, Jason Ho, Dionysos Slaga, Jeffrey Eastham-Anderson, Ji Li, Amy A. Lo, Nene Takahashi, Danielle Mandikian
Supplemental Methods, followed by Supplemental Figures S1, S2, S3, S4 and S5. Supplementary Fig. S1 In vitro binding of TDBs to HER2 and CD3 expressing cell lines. Supplementary Fig. S2 HER2 expression in model cell lines in vitro and tumors in vivo.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78af97c1976d313dca1f94037306ce27
https://doi.org/10.1158/1535-7163.22510396.v1
https://doi.org/10.1158/1535-7163.22510396.v1
Autor:
Maxwell V. Meng, Oliver A. Zill, Ximo Pechuan-Jorge, Charles Havnar, Nicolas Lounsbury, Daniel Oreper, Amy A. Lo, Sima P. Porten, Andrew Wallace
Supplementary Figure from Origins and Timing of Emerging Lesions in Advanced Renal Cell Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1a2ba16144a81b51648ad1ef608ca3e
https://doi.org/10.1158/1541-7786.22528067
https://doi.org/10.1158/1541-7786.22528067
Autor:
Teemu T. Junttila, Yan Wu, Jian Payandeh, C. Andrew Boswell, Genee Lee, Klara Totpal, James Ziai, Diego Ellerman, Dionysos Slaga, Elaine Mai, Daniel Bravo-Perez, Meric Ovacik, Hao Cai, Thinh Pham, Debra Dunlap, Kathy Hötzel, Wei-Ching Liang, Dorothee Nickles, Robyn Clark, Maria Hristopoulos, Danielle Mandikian, Ji Li, Jennifer Johnston, Amy A. Lo
Ovarian cancer is a diverse class of tumors with very few effective treatment options and suboptimal response rates in early clinical studies using immunotherapies. Here we describe LY6/PLAUR domain containing 1 (LYPD1) as a novel target for therapeu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05eedefc11b81d2abce20352199842ec
https://doi.org/10.1158/1535-7163.c.6543427
https://doi.org/10.1158/1535-7163.c.6543427
Autor:
Maxwell V. Meng, Oliver A. Zill, Ximo Pechuan-Jorge, Charles Havnar, Nicolas Lounsbury, Daniel Oreper, Amy A. Lo, Sima P. Porten, Andrew Wallace
Renal cell carcinoma (RCC) with venous tumor thrombus (VTT) arising from the primary tumor occurs in approximately 10% of cases and is thought to represent more advanced disease. The intravascular nature of VTT suggests that it may serve as a source
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bdbab156a135784664fac7fb17a983d
https://doi.org/10.1158/1541-7786.c.6545606
https://doi.org/10.1158/1541-7786.c.6545606
Autor:
Peiyin Wang, Liping L. Sun, Robyn Clark, Maria Hristopoulos, Cecilia P.C. Chiu, Michael Dillon, WeiYu Lin, Amy A. Lo, Sreedevi Chalsani, Meghna Das Thakur, Kristin M. Zimmerman Savill, Lionel Rougé, Patrick Lupardus, Robert Piskol, Bushra Husain, Diego Ellerman, Vittal Shivva, Steven R. Leong, Meric Ovacik, Klara Totpal, Yan Wu, Christoph Spiess, Genee Lee, Douglas D. Leipold, Andrew G. Polson
Publikováno v:
Molecular Cancer Therapeutics. 21:974-985
New therapeutics and combination regimens have led to marked clinical improvements for the treatment of a subset of colorectal cancer. Immune checkpoint inhibitors have shown clinical efficacy in patients with mismatch-repair–deficient or microsate